India Glycols Limited (INDIAGLYCO) – NCLT Approval of Scheme of Arrangement

Scrip Code: 500201
Symbol: INDIAGLYCO (BSE/NSE)

---

Introduction

India Glycols Limited (the “Company”) has filed a disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing the stock exchanges of a significant development concerning its proposed Scheme of Arrangement.

---

Key Development

• NCLT Order: On 17 July 2026, the Hon’ble National Company Law Tribunal (NCLT), Allahabad Bench at Prayagraj, issued an order sanctioning the Scheme of Arrangement previously announced by the Company.
• Scheme Overview:
  • Parties Involved:
    • India Glycols Limited (Demerged Company)
    • Ennature Bio Pharma Limited (Resulting Company 1 – “EBL”)
    • IGL Spirits Limited (Resulting Company 2 – “ISL”)
  • Business Segments:
    • Bio‑Pharma Undertaking to be transferred to EBL.
    • Spirits and Bio‑fuel Undertaking to be transferred to ISL.
  • Legal Basis: The scheme is being implemented under Sections 230‑232 of the Companies Act, 2013 and the corresponding rules.
• Prior Communication: This order follows an earlier intimation dated 3 July 2026 (reference IGL/SE/2026‑27/22) that announced the proposed demerger.

---

Next Steps

• The Company will upload the copy of the NCLT order on the Tribunal’s website once it becomes available and will submit it to the exchanges.
• No additional information or action is required from shareholders at this stage; the filing serves to keep the market duly informed.

---

Contact

• Ankur Jain – Head (Legal) & Company Secretary, India Glycols Limited
  • Email: ankur.jain@indiaglycols.com

This announcement is made in compliance with SEBI Listing Regulations and is intended solely for informational purposes.